Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

Skin symptoms appear in up to 20% of Covid-19 cases.

The normal range for the hair pull test is 2 hairs or fewer, and washing or brushing hair before the test does not affect the results.

PCOS increases the risk of heart disease and type 2 diabetes in women.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

Blood tests confirmed a baby in the womb had a CMV infection.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Certain drugs like Dutasteride and Finasteride might help fight SARS-CoV-2 by increasing levels of a steroid called DHEA, which can protect the heart and increase nitric oxide to counteract the virus.

Taking zinc supplements can help improve or cure hair loss caused by zinc deficiency.

No effective treatment for hair loss after childbirth was found, but it usually gets better on its own and some cosmetic methods might help.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

SARS-CoV-2 might infect and multiply in skin tissue, possibly aiding in its transmission.

COVID-19 may cause hair loss by affecting hair follicles.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Women using hair relaxers with alopecia had lower zinc levels, suggesting zinc deficiency might contribute to hair loss.

Accurate diagnosis and timely, tailored treatments improve outcomes in obstetrics and gynecology.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.